<DOC>
	<DOCNO>NCT02636556</DOCNO>
	<brief_summary>This study design evaluate feasibility safety concurrent chemoradiotherapy locally advance thymoma thymic carcinoma .</brief_summary>
	<brief_title>Study Chemoradiotherapy Inoperable Locally Advanced ( Stage Ⅲ/Ⅳa ) Thymoma Thymic Carcinoma</brief_title>
	<detailed_description>Complete resection difficult achieve without damage main organ locally advance thymoma thymic carcinoma . The previous trial show radiotherapy significantly associate prolonged OS chemotherapy play increase role treatment patient advance thymoma thymic carcinoma . However , whether concurrent chemoradiotherapy safety locally advanced thymoma thymic carcinoma still unknown . The purpose study evaluate feasibility safety concurrent chemoradiotherapy locally advance thymoma thymic carcinoma .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Thymoma</mesh_term>
	<mesh_term>Thymus Neoplasms</mesh_term>
	<criteria>18~75 year old ; Eastern Cooperative Oncology Group performance status 0 2 ; Pathologically cytologically confirm masaoka stage III IVa thymoma thymic carcinoma ; Have adequate bone marrow , hepatic , renal function ; Patients receive surgery resection ; Written inform consent . Patients distant metastasis ; Thymic carcinoid ; Patients underwent surgery , radiotherapy chemotherapy enter study ; Patients malignancy history exclude carcinoma situ cervix previous five year ; Active clinical pulmonary infection ; Pregnant nursing .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>thymoma</keyword>
	<keyword>thymic carcinoma</keyword>
	<keyword>chemoradiotherapy</keyword>
	<keyword>inoperable</keyword>
</DOC>